Kowal Investment Group, LLC Bristol Myers Squibb CO Transaction History

Kowal Investment Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $90,655 - $101,367	-1,566 Reduced 23.23%	5,174 $300,000
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $127 - $141	2 Added 0.03%	6,740 $431,000
Q1 2023 Apr 21, 2023	BUY	$65.71 - $74.53 $30,883 - $35,029	470 Added 7.5%	6,738 $467,000
Q4 2022 Jan 25, 2023	BUY	$68.48 - $81.09 $48,620 - $57,573	710 Added 12.77%	6,268 $0
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $86 - $51,175	666 Added 13.61%	5,558 $395,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $135,872 - $149,642	1,871 Added 61.93%	4,892 $377,000
Q1 2022 Apr 15, 2022	BUY	$61.48 - $73.72 $185,731 - $222,708	3,021 New	3,021 $221,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $45,800 - $53,392	-854 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $50,531 - $59,190	854 New	854 $51,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kowal Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Kowal Investment Group, LLC with notifications on news.